17 Stocks Moving In Wednesday's After-Hours Session

Gainers

• Applied Materials AMAT shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 EPS and sales guidance above estimates.
• TripAdvisor TRIP shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.
• CRISPR Therapeutics CRSP shares are trading higher after the company reported Q4 EPS of $0.51, up from $(0.92) year over year.
• ASGN ASGN shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.

Losers

• AVROBIO AVRO shares are trading lower after the company reported a $100 million common stock offering.
• Pluralsight PS shares are trading lower after the company reported better-than-expected Q4 EPS and sales results.
• Nu Skin NUS shares are trading lower after the company issued Q1 and FY20 sales guidance below estimates.
• SunPower SPWR shares are trading lower after the company reported worse-than-expected Q4 sales results.
• Turtle Beach HEAR shares are trading lower after the company issued preliminary Q4 and FY19 sales guidance below estimates.
• NetApp  NTAP shares are trading lower after the company reported worse-than-expected Q3 EPS and sales results. The company also issued Q4 EPS guidance below estimates.
• Qualys QLYS shares are trading lower after the company reported worse-than-expected Q4 sales results.
• CenturyLink CTL shares are trading lower after the company reported Q4 earnings.
• CoreCivic CXW shares are trading lower after the company reported Q4 FFO of $0.59, which is down from $0.63 year-over-year.
• Catalyst Biosciences CBIO shares are trading lower after the company reported a common stock offering of no disclosed size.
• TechTarget TTGT shares are trading lower after the company issued Q1 sales guidance below estimates.
• Avalara AVLR shares are trading lower after the company reported Q4 earnings.
• Change Healthcare CHNG shares are trading lower after the company reported worse-than-expected Q3 sales results.